MARKET

QTNT

QTNT

Quotient
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.06
-0.26
-4.89%
After Hours: 5.06 0 0.00% 16:00 09/23 EDT
OPEN
5.30
PREV CLOSE
5.32
HIGH
5.37
LOW
5.06
VOLUME
751.60K
TURNOVER
--
52 WEEK HIGH
10.38
52 WEEK LOW
2.395
MARKET CAP
497.10M
P/E (TTM)
-3.6048
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
A Biotech Pro Bought Up These 3 Stocks
Barrons.com · 4d ago
Insider Buys Quotient's Stock
Quotient Inc (NASDAQ:QTNT) was trading 6.6% higher from the previous closing price. Perceptive Advisors Llc filed a Form 4 with the SEC on Wednesday, September 16. The insider bought 2,911,764 shares at an average price of $4.25. After the transaction, the executive's stake in Quotient Inc. moved to 16,200,818 shares.
Benzinga · 09/16 15:07
Quotient's(NASDAQ:QTNT) Share Price Is Down 63% Over The Past Five Years.
It's nice to see the Quotient Limited (NASDAQ:QTNT) share price up 21% in a week. But don't envy holders -- looking...
Simply Wall St. · 09/14 20:37
Quotient Limited Announces Upsize and Pricing of Underwritten Offering of Ordinary Shares
JERSEY, Channel Islands, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT) (the Company), a commercial-stage diagnostics company, today announced the upsize and pricing of a $75 million underwritten public offering.  The Company is offering 17,647,059 ordinary shares at a price to the
GlobeNewswire · 09/11 01:42
RMTI, NCNO, GME and DPW among after-hours movers
Gainers: [[RMTI]] +29.3%. [[SLQT]] +13.7%. [[RH]] +13.5%. [[VRNT]] +7.6%. [[NCNO]] +7.5%.Losers: [[GME]] -11.1%. [[QTNT]] -8.3%. [[DPW]] -5.5%. [[BIGC]] -4.7%. [[LAMR]] -3.7%.
Seekingalpha · 09/09 21:32
Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares
JERSEY, Channel Islands, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an underwritten public offering of $60 million of its ordinary shares. All of the ordinary shares to be sold
GlobeNewswire · 09/09 21:05
Quotient reboots distribution deal with Ortho
Quotient Limited (QTNT) inks a binding letter of intent with Ortho Clinical Diagnostics terminating their former distribution agreement and related contracts and resolving their disputes over the deal.The parties have
Seekingalpha · 09/08 10:41
Quotient Limited And Ortho Clinical Diagnostics Settle Arbitration And Sign Binding Letter Of Intent Covering Patient Transfusion Diagnostics; Under Agreement, Quotient Entitled To Payments Of Up To $67.5M
  JERSEY, Channel Islands, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), headquartered in Eysins, Switzerland, today announced that the Company and Ortho Clinical Diagnostics (Ortho) have
Benzinga · 09/08 10:17
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of QTNT. Analyze the recent business situations of Quotient through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average QTNT stock price target is 13.50 with a high estimate of 14.00 and a low estimate of 13.00.
EPS
Institutional Holdings
Institutions: 140
Institutional Holdings: 74.30M
% Owned: 75.63%
Shares Outstanding: 98.24M
TypeInstitutionsShares
Increased
37
10.19M
New
44
-2.29M
Decreased
21
4.39M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.43%
Healthcare Equipment & Supplies
-1.48%
Key Executives
Chairman/Independent Director
Heino von Prondzynski
Chairman/Independent Director
Heino.N.F.M von Prondzynski
Chief Executive Officer/Director
Franz Walt
Chief Financial Officer
Peter Buhler
Chief Operating Officer
Edward Farrell
Treasurer
Ernest Larnach
Other
Jeremy Stackawitz
Independent Director
Thomas Bologna
Independent Director
Isabelle Buckle
Independent Director
Frederick Hallsworth
Independent Director
Catherine Larue
Independent Director
Brian McDonough
Independent Director
Sarah O'Connor
Independent Director
Zubeen Shroff
Independent Director
John Wilkerson
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About QTNT
Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It is engaged in developing MosaiQ, which is its technology platform. The Company develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Its antisera products contain antibodies used to identify blood group antigens. Its antisera products are monoclonal antibodies manufactured from master cell lines it owns. Its reagent red blood cells products are composed of human red blood cells formulated to enable the identification of blood group antibodies. The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Quotient Ltd stock information, including NASDAQ:QTNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QTNT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading QTNT stock methods without spending real money on the virtual paper trading platform.